$GENB SEC Filings

Filed On	Filing
03 Sep 2026	Form 4: Arnold Frances, Director Sold 1,000 shares ($16K)
02 Sep 2026	144
01 Sep 2026	144
26 Aug 2026	8-K: Regulation FD Disclosure
06 Aug 2026	10-Q
06 Aug 2026	8-K: Results of Operations and Financial Condition
15 May 2026	SCHEDULE 13G
15 May 2026	SCHEDULE 13G
07 May 2026	10-Q
07 May 2026	8-K: Results of Operations and Financial Condition
12 Mar 2026	Form 3: Pioneering Medicines 02, Llc, 10% owner Holds 1,562,500 shares of Common Stock
06 Mar 2026	Form 4: Nally Michael, Director Bought 20,000 shares ($240K)
02 Mar 2026	Form 4: Vessey Rupert, Director Granted 29,561 Stock Option (Right to Buy)
02 Mar 2026	Form 4: Grous Beth, Chief People Officer Granted 114,020 Stock Option (Right to Buy) · Bought 300 shares ($4.8K)
02 Mar 2026	Form 4: Arnold Frances, Director Granted 29,561 Stock Option (Right to Buy)
02 Mar 2026	Form 4: Lee Laurie Anne, Chief Medical Officer Granted 42,230 Stock Option (Right to Buy)
02 Mar 2026	Form 4: Martin Sean, Chief Legal Officer & GC Granted 190,034 Stock Option (Right to Buy)
02 Mar 2026	Form 4: Simonian Nancy A, Director Granted 29,561 Stock Option (Right to Buy)
02 Mar 2026	Form 4: Silvers Jason, President & CFO Granted 570,101 Stock Option (Right to Buy) · Bought 2,000 shares ($32K)
02 Mar 2026	Form 4: Afeyan Noubar, Director and 7 others Granted 29,561 Stock Option (Right to Buy) · Received 32,969,159 shares by conversion · Bought 4,687,500 shares ($75M)

Comments